Airline Crews Report Brain and Nerve Damage After Exposure to Contaminated Cabin Air, Investigation Finds
Records and interviews show thousands of fume reports since 2010 and a rise in incidents tied to Airbus A320 aircraft, prompting medical concern and industry responses.
Scores of pilots and flight attendants have reported brain and nerve damage after inhaling fumes that investigators say leaked into cockpits and cabins, according to a Wall Street Journal investigation and airline records. Since 2010, thousands of reports filed with the Federal Aviation Administration described air that crews said was contaminated; health providers and former crew members say injuries range from acute neurological symptoms to long-term cognitive and nerve damage.
The records show the number of reported fume events has risen in recent years and that Airbus’s A320 family of jets was associated with a disproportionate share of incidents. The FAA describes such events as rare, but the Journal’s review found the rate of fume incidents had climbed to nearly 108 per million departures in recent years. Airlines, manufacturers and regulators have acknowledged some oil and hydraulic fluids can vaporize at engine temperatures and enter the unfiltered bleed-air system used on many jets.
Crew members and medical specialists described repeated and sometimes severe effects. JetBlue flight attendant Florence Chesson told investigators she suffered a traumatic brain injury and permanent nerve damage after a flight to Puerto Rico during which she said she felt “drugged” and later experienced burning sensations in her brain. Former airline pilot Susan Michaelis, who had publicly campaigned about contaminated cabin air, died earlier this year; her doctors said her slow-growing lobular breast cancer was related to chemical exposures she reported during her flying career.
Neurologists and occupational medicine specialists who have treated affected crew say the pattern of injury can resemble repeated concussions seen in contact sports. Dr. Robert Kaniecki, who told the Journal he has treated more than 100 flight attendants and about a dozen pilots for brain injuries tied to toxic cabin air, described repeated exposures as “micro concussions” that can prime patients for a more serious event. Dr. Robert Harrison at the University of California, San Francisco, said he has treated more than 100 aircrew members for similar injuries and called the problem real and medically significant.
A number of high-profile incidents illustrate the range of events and outcomes. In one flight, passengers and crew were ordered to breathe through clothing and stay low after thick white smoke poured through overhead vents and the pilots declared an emergency; the plane returned to Atlanta. Footage from a passenger captured a smoky haze filling the cabin. A JetBlue pilot, Andrew Myers, reportedly collapsed while inhaling fumes during a maintenance test and was later diagnosed with a chemical-induced nervous system injury; his loss of an FAA medical certificate led to a court case that recognized long-term health damage from a fume event.
Records reviewed by the Journal indicate a spike in fume events at carriers that operate large fleets of A320 family aircraft. JetBlue and Spirit, both with predominantly Airbus narrow-body fleets, showed a 660% rise in reported A320 fume incidents between 2016 and 2024, according to the records. In 2016 Airbus relaxed certain maintenance requirements that allowed aircraft emitting noticeable odors to remain in service without immediate inspection, a change that has drawn scrutiny amid the rise in reported events.
Regulatory and industry responses have been mixed. The FAA has characterized tainted-air incidents as rare and continues to fund studies of cabin air quality. A recent FAA-funded study found that when engine oils and hydraulic fluids were vaporized at engine heat levels, some chemical concentrations—such as formaldehyde and tridecane—exceeded workplace safety limits. An FAA safety inspector warned in 2018 that organophosphates present in modern jet oils, once used as nerve agents in warfare, were entering cabins unfiltered.
Airlines have said they take reports seriously and have taken steps to reduce the likelihood of events. A Delta representative said the carrier’s safety management system and culture focus on identifying root causes and that smoke, fumes and odor events are exceedingly rare. Delta said it has been replacing auxiliary power units on its A320-family jets, work it described as more than 80% complete. Airbus said its aircraft meet applicable airworthiness requirements and described a redesign effort called Project Fresh, intended to relocate a bleed-air vent; that redesign is slated to apply to new jets starting in 2026 and was said by Airbus to reduce cabin odor events by as much as 85%.
Boeing and Airbus have publicly maintained that cabin air on their airplanes is safe. Internal communications disclosed in litigation show that some Boeing employees had raised concerns years ago about oil leaks and potential health effects; one 2017 email quoted a quality inspector warning that oil leaks could make "aircrew sick to the point of death." Boeing has continued to assert publicly that cabin air is safe.
The medical community and affected crew members have urged additional research, stronger reporting and faster remedial steps. Some physicians treating these patients have compared their symptoms to the traumatic brain injuries documented in professional athletes, and say repeated low-level exposures can produce cumulative damage. Regulators, manufacturers and airlines say they are studying technical fixes and operational changes to mitigate risks while inspections, maintenance changes and litigation proceed.
Investigations, medical reports and legal claims continue to shape debate over the frequency and severity of contaminated-air events and the adequacy of current systems to detect and prevent them. Families of affected crew and some former employees are pursuing compensation and policy changes, and several experts and lawmakers have called for broader testing and stricter maintenance and design requirements. The airlines and manufacturers contend that safety remains the top priority and that technical solutions are under development or already being implemented.
As research and litigation progress, regulators and industry officials face pressure to reconcile operational practices with mounting medical reports and to determine whether design changes and additional monitoring should be accelerated across commercial fleets.